Naringenin: A Promising Therapeutic Agent against Organ Fibrosis
Fibrosis is the final common pathology of most chronic diseases as seen in the heart, liver, lung, kidney, and skin and contributes to nearly half of death in the developed countries. Fibrosis, or scarring, is mainly characterized by the transdifferentiation of fibroblasts into myofibroblasts and th...
Guardado en:
Autores principales: | Yanfei Du, Jun Ma, Yu Fan, Xinyu Wang, Shuzhan Zheng, Jian Feng, Jiafu Li, Zhongcai Fan, Guang Li, Qiang Ye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e6d786fb4d1440299b7020cd8afc664 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Temporary Upregulation of Nrf2 by Naringenin Alleviates Oxidative Damage in the Retina and ARPE-19 Cells
por: Wenpei Chen, et al.
Publicado: (2021) -
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
por: Yani Wang, et al.
Publicado: (2021) -
Ghrelin Ameliorates Diabetic Retinal Injury: Potential Therapeutic Avenues for Diabetic Retinopathy
por: Jie Bai, et al.
Publicado: (2021) -
Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
por: Álvarez D, et al.
Publicado: (2015) -
Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer
por: Yanfei Shao, et al.
Publicado: (2021)